Intrathymic T cell development depends on signals transduced by both T cell receptor and cytokine receptors. Early CD4−CD8− (double negative) thymocytes require interleukin (IL)-7 receptor (IL-7R) signals for survival and proliferation, but IL-7R signals are normally extinguished by the immature single positive (ISP) stage of thymocyte development. We now demonstrate that IL-7R signals inhibit expression of transcription factors TCF-1, LEF-1, and RORγt that are required for the ISP to double positive (DP) transition in the thymus. In addition, we demonstrate that IL-7R signals also inhibit TCF-1 and LEF-1 expression in mature peripheral T cells. Thus, the present work has identified several important downstream target genes of IL-7R signaling in T cells and thymocytes that provide a molecular mechanism for the inhibitory influence of IL-7R signaling on DP thymocyte development. We conclude that IL-7R signals down-regulate transcription factors required for the ISP to DP transition and so must be terminated by the ISP stage of thymocyte development.
Skip Nav Destination
Article navigation
20 September 2004
Article Contents
Brief Definitive Report|
September 13 2004
IL-7 Receptor Signals Inhibit Expression of Transcription Factors TCF-1, LEF-1, and RORγt : Impact on Thymocyte Development
Qing Yu,
Qing Yu
1Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Search for other works by this author on:
Batu Erman,
Batu Erman
1Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Search for other works by this author on:
Jung-Hyun Park,
Jung-Hyun Park
1Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Search for other works by this author on:
Lionel Feigenbaum,
Lionel Feigenbaum
2SAIC-Frederick, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, MD 21702
Search for other works by this author on:
Alfred Singer
Alfred Singer
1Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Search for other works by this author on:
Qing Yu
1Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Batu Erman
1Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Jung-Hyun Park
1Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Lionel Feigenbaum
2SAIC-Frederick, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, MD 21702
Alfred Singer
1Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Address correspondence to Alfred Singer, Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bldg. 10, Rm. 4B36, Bethesda, MD 20892. Phone: (301)-496-5461; Fax: (301)-496-0887; email: [email protected]
Received:
December 16 2003
Accepted:
July 16 2004
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2004
J Exp Med (2004) 200 (6): 797–803.
Article history
Received:
December 16 2003
Accepted:
July 16 2004
Citation
Qing Yu, Batu Erman, Jung-Hyun Park, Lionel Feigenbaum, Alfred Singer; IL-7 Receptor Signals Inhibit Expression of Transcription Factors TCF-1, LEF-1, and RORγt : Impact on Thymocyte Development . J Exp Med 20 September 2004; 200 (6): 797–803. doi: https://doi.org/10.1084/jem.20032183
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement